Company / Shares Outstanding
CytomX Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
137.9M
FY2025
5-year range
65.4M / 137.9M
FY2021-FY2025
Trend
+72.2%
vs FY2024
Sector context
#70 of 212
Health Care
What the data says
At 137935873.00, CytomX Therapeutics, Inc.'s shares outstanding ranks #143 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 45523088.00 in FY2020 to 137935873.00 in FY2025.
Based on SEC 10-K filings.
137935873.00 in FY2025 with a 5-year CAGR of +24.8%.
Increased from 67310838.00 to 137935873.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +27.7%
- 5-Year CAGR
- +24.8%
- 10-Year CAGR
- -
Sector benchmark
#143 of 212 in Health CareTop 67% of 212This company 137.9M Sector average 306.7M
▼
-55.0% below sector average
Key checks
Key Insights
- CytomX Therapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2025, shares outstanding increased 72.2% year-over-year.
- Ranks #70 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.68 (distress zone, below 1.8 threshold)
- Strong profit margin: 23.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 137.9M | +72.2% |
| FY2024 | 80.1M | +19.0% |
| FY2023 | 67.3M | +1.6% |
| FY2022 | 66.2M | +1.3% |
| FY2021 | 65.4M | +43.6% |
| FY2020 | 45.5M | +0.0% |
| FY2019 | 45.5M | +1.0% |
| FY2018 | 45.1M | +17.2% |
| FY2017 | 38.5M | +5.4% |
| FY2016 | 36.5M | +3561.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026